Third Harmonic Bio Announces Phase 1 Clinical Results for THB335 and Provides Corporate Strategic Update
THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU)Company initiating process to leverage ...
Jasper Therapeutics Announces Briquilimab Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of ...
Daily Record7d
Woman allergic to rain and water says washing hands caused rashes
In October 2022, she began experiencing hives when her skin came into contact with water. Her reactions were sometimes so ...
EAACI-ESCD Skin Allergy Meeting (SAM) 2025: Pioneering Innovations in Skin Allergy and Contact Dermatitis
The Organising Committee is delighted to announce the seventh edition of the EAACI-ESCD Skin Allergy Meeting (SAM), Europe’s leading event dedicated to skin allergies. This year, SAM 2025 will take ...
Mena FN8d
Alys Pharmaceuticals Receives IND Clearance For Phase 2A Trial Of First Genetic Medicine Program In Dermatology
This marks the first clinical study from the Alys pipeline, which includes a broad portfolio of assets targeting unmet needs in additional indications such as atopic dermatitis, chronic spontaneous ...
Healio9d
AAAAI president-elect hopes to develop valuable resources, help residents get involved
In his 2025 to 2026 term as American Academy of Allergy, Asthma & Immunology president, Frank S. Virant, MD, FAAAAI, plans to ...
Zevra Therapeutics to Present at the 21st Annual WORLDSymposium™
Zevra to receive a 2025 New Treatment Award for MIPLYFFA™ at the 21st Annual WORLDSymposiumEight abstracts discussing data and clinical ...
Allakos Announces Topline Results from its Phase 1 Trial of AK006 in Patients with Chronic Spontaneous Urticaria and Announces Restructuring
SAN CARLOS, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Allakos Inc. (Company) (Nasdaq: ALLK), today announced topline results from its phase 1 clinical trial of AK006 in chronic spontaneous urticaria ...
verywellhealth19d
Common Causes and Treatments for Itching
There are three common allergic skin conditions that cause itching. These include atopic dermatitis (eczema), hives (urticaria), and contact dermatitis. If the cause of the itching is identified and ...
Medscape21d
When Plants Attack: Diagnosing and Managing Phytodermatoses
Contact urticaria can be nonimmunological, as seen with nettles, which rapidly cause painful papules due to the release of histamine, acetylcholine, and 5-hydroxytryptophan. In some cases ...
FOX8 Cleveland22d
You actually can be allergic to the cold, local hospital says
The human body can actually have a physical reaction to the cold, it turns out. Cold urticaria is an allergic reaction that presents as hives, usually on the arms and legs, pediatric allergy and ...
Pharmaceutical Technology24d
Remibrutinib by Novartis for Chronic Urticaria Or Hives: Likelihood of Approval
Remibrutinib is under clinical development by Novartis and currently in Phase III for Chronic Urticaria Or Hives. According to GlobalData, Phase III drugs for Chronic Urticaria Or Hives have a 67% ...